Literature DB >> 19618339

Viliuisk encephalomyelitis in Eastern Siberia - analysis of 390 cases.

Lev G Goldfarb1, Vsevolod A Vladimirtsev, Fyodor A Platanov, Hee-Suk Lee, Catriona A McLean, Colin L Masters.   

Abstract

Viliuisk encephalomyelitis (VE) is a unique disease occurring in the Yakut (Sakha) population of Eastern Siberia. VE is always fatal, with some patients dying during the acute encephalitic phase of illness; those surviving the acute phase develop progressive dementia, rigidity and spastic quadriparesis as part of a more prolonged pan-encephalitic syndrome. The disease is characterized neuropathologically by multiple widespread micronecrotic foci with marked inflammatory reactions and subsequent gliosis throughout the cerebral cortex, basal ganglia, cerebellum and brain stem. The acute febrile onset with cerebrospinal fluid pleocytosis and increased protein and neuropathology showing inflammatory reactions suggest that VE is an infectious disease, but the causative agent has not been identified. Initially detected in a small mixed Yakut-Evenk population of the mid-Viliui region, the disease subsequently spread south to densely populated areas around the capital city of Yakutsk. The occurrence of secondary VE cases in households and the introduction of the disease by migrants into new populations indicate that the disease is horizontally transmitted in a setting of a long intra-household contact. Although there has been a recent decline in the number of cases, increasing travel may result in further spread of this fatal disease to susceptible individuals in other regions of the world.

Entities:  

Mesh:

Year:  2009        PMID: 19618339      PMCID: PMC2760956     

Source DB:  PubMed          Journal:  Folia Neuropathol        ISSN: 1509-572X            Impact factor:   2.038


  18 in total

1.  Viliuisk encephalomyelitis in the Iakut people of Siberia.

Authors:  L G Goldfarb; D C Gajdusek
Journal:  Brain       Date:  1992-08       Impact factor: 13.501

2.  IMMUNOLOGICAL CHARACTERIZATION OF VILYUISK HUMAN ENCEPHALOMYELITIS VIRUS.

Authors:  J CASALS
Journal:  Nature       Date:  1963-10-26       Impact factor: 49.962

3.  [Viinius encephalitis (encephalomeningitis)].

Authors:  P A PETROV
Journal:  Zh Nevropatol Psikhiatr Im S S Korsakova       Date:  1958

4.  Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination.

Authors:  H L Lipton
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

5.  Viliuisk encephalomyelitis--review of the spectrum of pathological changes.

Authors:  C A McLean; C L Masters; V A Vladimirtsev; I A Prokhorova; L G Goldfarb; D M Asher; A I Vladimirtsev; V P Alekseev; D C Gajdusek
Journal:  Neuropathol Appl Neurobiol       Date:  1997-06       Impact factor: 8.090

6.  Foci of motor neuron disease in high incidence in isolated populations of East Asia and the Western Pacific.

Authors:  D C Gajdusek
Journal:  Adv Neurol       Date:  1982

7.  [Nosological classification of bokhoror].

Authors:  G L Zubri; K G Umanskiĭ; A P Savinov; M N Korotov; V A Baranov
Journal:  Genetika       Date:  1977

8.  [Correlation of heredity and environmental factors in the etiology of Vilyui encephalomyelitis. II. A population genetic study in districts of Vilyui encephalomyelitis distribution].

Authors:  L B Gol'dfarb; V A Spitsyn; N I Fedorova; M P Chumakov; S B Boeva
Journal:  Genetika       Date:  1979

9.  [Clinical picture and histopathology of Viliuisk encephalomyelitis].

Authors:  A P Avtsyn; I A Prokhorova; A A Zhavoronkov; L G Gol'dfarb
Journal:  Zh Nevropatol Psikhiatr Im S S Korsakova       Date:  1983

10.  [Correlation of heredity and environmental factors in the etiology of Vilyui encephalomyelitis. I. Patient frequency in families].

Authors:  L G Gol'dfarb; N I Fedorova; M P Chumakov; P A Petrov; A I Vladimirtsev
Journal:  Genetika       Date:  1979
View more
  1 in total

1.  Communicating hydrocephalus following eosinophilic meningitis is pathogenic for chronic Viliuisk encephalomyelitis in Northeastern Siberia.

Authors:  Alexander Storch; Jan Kassubek; Hayrettin Tumani; Vsevolod A Vladimirtsev; Andreas Hermann; Vladimir L Osakovsky; Vladimir A Baranov; Vadim G Krivoshapkin; Albert C Ludolph
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.